Tyrosine kinase signaling in fibrotic disorders: Translation of basic research to human disease.
about
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepNew Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical TrialsPharmacology and rationale for imatinib in the treatment of sclerodermaThe fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance.High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts.Idiopathic pulmonary fibrosis and cancer: do they really look similar?Dasatinib Attenuates Pressure Overload Induced Cardiac Fibrosis in a Murine Transverse Aortic Constriction ModelInterplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis.Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic diseaseInjectable nanofibrous spongy microspheres for NR4A1 plasmid DNA transfection to reverse fibrotic degeneration and support disc regeneration.The epidermal growth factor receptor pathway in chronic kidney diseases.Src family kinases in chronic kidney disease.Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis.Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis.Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease.Suspected accelerated disease progression after discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: Two case reports.Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres.Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation.The activity of nintedanib in an animal model of allogenic left lung transplantation resembling aspects of allograft rejection.Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.A novel computational approach for drug repurposing using systems biology.The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis.Traumatic muscle fibrosis: From pathway to prevention.Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling.Impact of sorafenib on epidural fibrosis: An immunohistochemical study
P2860
Q26771518-64B4559B-E175-40A1-90C5-58509A8DC679Q26772800-BF6C4C22-05F8-426E-818F-044927E0D078Q26825153-553E5FB1-97E6-40F1-BEB6-74C6EAD45AE1Q33586556-54AC38A9-5449-43CD-B763-FC3A264F9443Q35616490-D6D7DB80-325F-4252-B1A4-BC5AC9C6278FQ35785589-DA454996-D4F9-49D6-AE93-6FA09CDB41EAQ35803480-BCD487FB-C606-412A-AFBD-663749E29DC2Q36339714-2049FA3A-8089-4281-B645-E10B512E5131Q38134341-8B435C9B-35D3-45D5-9535-9A4EACD8A523Q38202115-F7074FC8-D38B-4AA2-96AD-F3134B227354Q38855505-54C037CA-C2A5-4A47-98FE-FCC605BD76D6Q38885079-FDB0BDCE-2585-47AA-95B3-FC1866E87842Q40159797-9AB5C666-FFCE-4BAC-9C3F-1D369A198D41Q41592573-6AC685C2-FA36-45CB-97A9-BB432F682AFFQ42022291-8F474A0B-0471-4ACF-B501-97BC4EC16340Q45971063-B0EDB6AE-7511-4764-A089-A6FB4AB65178Q45975840-56038467-A1CD-4438-80EA-3C384209D0C0Q47118064-81E15EB1-404C-454A-AB54-DE4006C24A71Q47161826-72390C70-EEA9-434C-BF5E-187C02884C77Q49795395-7BDFCB11-B4A2-45DC-8F04-65FE6F59ECEEQ50073523-53B3EF9D-1D3A-42E6-8C83-D3C5AF9E5712Q50448734-9EFE0563-2D79-4509-8A78-25A714A70F6FQ52657953-A18B2EAF-F9D9-44D7-83FD-1706CB3DE00DQ53381128-FDBA23D8-AB04-4A23-8ECA-465FB2821DBAQ54062963-744D4DAE-DA1C-4BEC-83AA-EBCA54AB1D79Q54375096-CB1F5708-1199-4EFA-A735-F465288BF9FAQ58761576-110A7A74-A3BC-44E9-8980-8C9CD9A348A8
P2860
Tyrosine kinase signaling in fibrotic disorders: Translation of basic research to human disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Tyrosine kinase signaling in f ...... sic research to human disease.
@en
Tyrosine kinase signaling in f ...... sic research to human disease.
@nl
type
label
Tyrosine kinase signaling in f ...... sic research to human disease.
@en
Tyrosine kinase signaling in f ...... sic research to human disease.
@nl
prefLabel
Tyrosine kinase signaling in f ...... sic research to human disease.
@en
Tyrosine kinase signaling in f ...... sic research to human disease.
@nl
P1476
Tyrosine kinase signaling in f ...... sic research to human disease.
@en
P2093
Jörg H W Distler
P304
P356
10.1016/J.BBADIS.2012.06.008
P577
2012-06-19T00:00:00Z